FoxO3 Activation Alleviates Doxorubicin‐Induced Cardiomyopathy by Enhancing Autophagic Flux and Suppressing mTOR / ROS Signalling
Journal of Cellular and Molecular Medicine · 2025-08 · 29 (15)
DOI: 10.1111/jcmm.70775 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 10.08.2025. Verfasst von Zao-Shang Chang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Pu ai Medical School, Shaoyang University, Shaoyang, Hunan, China. Hauptthemen laut MEDLINE: Forkhead Box Protein O3, Autophagy, TOR Serine-Threonine Kinases, Doxorubicin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Scientific Research Project of Hunan Provincial Department of Education, National Natural Science Foundation of China, Characteristic Innovation Project of Guangdong Provincial Education Department.
Abstract (Originalsprache)
Doxorubicin (DOX) is an effective chemotherapy drug, but its use is limited by cardiotoxicity, known as DOX‐induced cardiomyopathy. The transcription factor FoxO3, which regulates autophagy and oxidative stress, has unclear mechanisms in this condition. We found that DOX‐induced cardiomyopathy involved cardiac atrophy, cardiac dysfunction, fibrosis and mitochondrial damage. DOX reduced H9c2 cardiomyocyte viability and glutathione levels (GSH), increased reactive oxygen species (ROS), malondialdehyde (MDA) and lactate dehydrogenase (LDH) and inhibited superoxide dismutase 2 ( SOD2 ) and catalase ( CAT ) expression. DOX also suppressed FoxO3 activation and increased the autophagy protein LC3 II/I ratio. Overexpressing FoxO3 enhanced LC3B, Beclin 1 and autophagic flux, while reducing p62 and suppressing mTOR activation in heart. Brefeldin A1 (BafA1), an autophagy inhibitor and rapamycin (Rapa), an autophagy activator, were administered to H9c2 cardiomyocytes to elucidate the regulatory mechanism of FoxO3 . Mechanically, our data revealed that FoxO3 overexpression enhanced autophagy and suppressed ROS production and mTOR activation in both in vitro and in vivo models of DOX exposure. Collectively, targeting FoxO3 to enhance protective autophagy may offer a therapeutic strategy against DOX‐induced cardiomyopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Pu ai Medical School, Shaoyang University, Shaoyang, Hunan, China.
- Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, Guangdong, China.
- Department of Pharmacy, The Central Hospital of Shaoyang, Shaoyang, Hunan, China.
- School of Nursing, Shaoyang University, Shaoyang, Hunan, China.
- Guangdong Provincial Key Laboratory of Physical Activity and Health Promotion, Guangzhou Sport University, Guangzhou, Guangdong, China.
ORCID-Profile: Jing-Bo Xia
Förderung
- Key Scientific Research Project of Hunan Provincial Department of Education
- National Natural Science Foundation of China
- Characteristic Innovation Project of Guangdong Provincial Education Department
- Guangzhou Basic Research Plan, Basic and Applied Basic Research Project
- Hunan Provincial Natural Science Foundation of China
- Hunan Province from science and technology enterprises and institutions entrusted project
- General Scientific Research Project of Hunan Provincial Department of Education
Zitieren
APA
Chang, Z. S., Wang, L., Zhou, J. X., Li, M. X., Yang, M. Y., Luo, B., Liu, J. J., Sun, X. Y., & Xia, J. B. (2025). FoxO3 Activation Alleviates Doxorubicin‐Induced Cardiomyopathy by Enhancing Autophagic Flux and Suppressing mTOR / ROS Signalling. Journal of Cellular and Molecular Medicine, 29(15). https://doi.org/10.1111/jcmm.70775
Vancouver
Chang ZS, Wang L, Zhou JX, Li MX, Yang MY, Luo B, et al. FoxO3 Activation Alleviates Doxorubicin‐Induced Cardiomyopathy by Enhancing Autophagic Flux and Suppressing mTOR / ROS Signalling. Journal of Cellular and Molecular Medicine. 2025;29(15). doi:10.1111/jcmm.70775
BibTeX
@article{Chang2025,
author = {Chang, Zao-Shang and Wang, Le and Zhou, Ju-Xiang and Li, Mei-Xiu-Li and Yang, Meng-Yun and Luo, Bin and Liu, Jia-Jun and Sun, Xiao-Ye and Xia, Jing-Bo},
title = {FoxO3 Activation Alleviates Doxorubicin‐Induced Cardiomyopathy by Enhancing Autophagic Flux and Suppressing mTOR / ROS Signalling},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {15},
doi = {10.1111/jcmm.70775}
}
EUVIMED